Investors React as Grifols' Transparency Gets Questioned by Gotham City Research
Wednesday, 6 March 2024, 11:30
Grifols' Stock Plummets Amid Allegations by Short-Seller
Shares in the Spanish medicine maker fell 14% after Gotham City Research questioned its transparency. The market reacted swiftly to the report, with investors expressing concerns over the credibility of Grifols' financial disclosures and operational practices.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.